United States. Food and Drug Administration. Bureau of Drugs

• FDA interim index to evaluations published in the Federal register for NAS-NRC reviewed prescription drugs
• Guidelines for the clinical evaluation of anti-infective drugs (systemic)
• Guidelines for the clinical evaluation of anti-inflammatory and antirheumatic drugs (adults and children)
• Guidelines for the clinical evaluation of anti-inflammatory drugs (adults and children)
• Guidelines for the clinical evaluation of anticonvulsant drugs (adults and children)
• Guidelines for the clinical evaluation of antiepileptic drugs (adults and children)
• Guidelines for the clinical evaluation of G.I. motility-modifying drugs
• Guidelines for the clinical evaluation of gastric secetory depressant (GSD) drugs
• Guidelines for the clinical evaluation of general anesthetics
• Guidelines for the clinical evaluation of laxative drugs